Connect with us

News

Do we really need CBD hand sanitiser?

Published

on

Sales of sanitising products are set to reach $17.2 Billion by 2026

A new antibacterial CBD and CBG infused hand sanitiser has launched on the US market – but can cannabinoids really help protect you from infection?

Since the start of the coronavirus pandemic hand sanitiser has become everyone’s must-have accessory. 

During one week in February 2020, sales of hand gel in US pharmacies increased by more than 80 percent on the same period the previous year and the global hand sanitiser market is projected to grow significantly to reach $17.2 Billion by 2026.

Now US skin and personal care company Naturaholic has announced it is expanding into CBD –  it’s first product? Hand sanitiser infused with CBD and CBG.

Nahid LaCiura, the founder and lead product director of Naturaholic announced earlier this year that the company would put focus on adding different cannabinoids into their already successful natural product line.

“Early 2020, as our research into a new CBD skincare line began, Covid-19 struck which turned the company’s attention into a totally different direction in order to fill in the void in the marketplace and keep our community safe,” said Nahid.

“It only made sense for us to turn our focus to offering a hand sanitizer that would be strong and efficient enough yet gentle and moisturising.

“Also since we are an online company we could reach many people around the country in need of this high-demand product.”

Why use a CBD and CBG hand sanitiser? 

A Journal of Natural Products research article published in 2008 by the American Chemical Society reported that cannabidiol (CBD) and cannabigerol (CBG), two of the most abundant cannabinoids found in hemp, “showed potent activity against a variety of MRSA strains in mice.” 

Nahid added: “For those that don’t know, MRSA is the antibiotic resistant “superbug” that haunts the halls of many hospitals and healthcare facilities. 

“The infection caused by MRSA is very difficult to treat because of its resistance to most antibiotics.”

This issue has enormous clinical implications since MRSA is spreading throughout the world. In the United States MRSA accounts for killing nearly 19,000 Americans every year — more than the nation’s annual number of AIDS deaths (which is around 13,000).

“Although the use of cannabinoids as systemic antibacterial agents are still lacking rigorous clinical trials, they are well-suited antibiotic and sanitizing agents when applied topically, particularly against gram-positive pathogens including MRSA,” continued Nahid.

“For a hand sanitizer to have such a property, this could help many people through this hard time. The science behind this is CGB’s ability to stop the growth of biofilms by destroying the cell membrane of the microorganisms architecture, while also halting the growth of any new biofilms as well. The Paper published by McMaster University in Canada is a very interesting read if you’re into the science behind it.

“As it stands now, though it’s only been a few months, the CBD+CBG hand sanitizer is outselling most of our other products. 

“Of course, the Hyaluronic Acid and Skin Tightening Oil are still on top, but we can’t discount the amazing performance the hand sanitizer is having.”

The CBD+CBG hand sanitizer is available in 4 oz at a 1:1 ratio of CBD to CBG with 200mg potency. 

The formula uses ethanol alcohol at over a 60 percent potency in a gel formula with added Vitamin E and cannabinoids. This product is FDA registered and comes complete with 3rd party lab testing and COA (Certificate of Analysis) to guarantee potency.

Naturaholic is an artisanal line of skin and personal care products handcrafted in small batches  using high quality organic ingredients.

Sarah Sinclair is an award-winning freelance journalist covering health, drug policy and social affairs. She is one of the few UK reporters specialising in medical cannabis policy and as the former editor of Cannabis Health has covered developments in the European cannabis sector extensively, with a focus on patients and consumers. She continues to report on cannabis-related health and policy for Forbes, Cannabis Health and Business of Cannabis and has written for The i Paper, Byline Times, The Lead, Positive News, Leafie & others. Sarah has an NCTJ accreditation and an MA in Journalism from the University of Sunderland and has completed additional specialist training through the Medical Cannabis Clinicians Society in the UK. She has spoken at leading industry events such as Cannabis Europa.

Trending

Cannabis Health is a journalist-led news site. Any views expressed by interviewees or commentators do not reflect our own. All content on this site is intended for educational purposes, please seek professional medical advice if you are concerned about any of the issues raised.

Copyright © 2024 PP Intelligence Ltd.